Prima Nexus / Events / 2016

5th National Conference on Laboratory Animal Science (5th NCLAS) and 21st LASAM AGM

Prima Nexus sponsored the 5th National Conference on Laboratory Animal Science (5th NCLAS), held with the 21st LASAM Annual General Meeting at Grand Seasons Hotel, Kuala Lumpur, on 18 August 2016.

· Conference · Sponsored by Prima Nexus

Four conference delegates wearing name badges stand together in the hotel
Delegates at the conference.

About the conference

The Laboratory Animal Science Association of Malaysia (LASAM) held the 5th National Conference on Laboratory Animal Science together with its 21st Annual General Meeting on 18 August 2016 at Grand Seasons Hotel, Kuala Lumpur.

Talks covered the Animal Welfare Act 2015, veterinary pathology, the sourcing of laboratory animals, tissue imaging and mouse models in research, with speakers from the Department of Veterinary Services, universities, research institutes and industry.

Prima Nexus’s part

Prima Nexus was the conference sponsor named in the programme book. The organising committee also invited Prima Nexus to present a talk on laboratory animal resources and why the quality of laboratory animals matters in research and testing.

For Prima Nexus’s laboratory animal services today, see the animal studies page.

More of our work with UKM, UPM, Nuclear Malaysia, IMR, UiTM, UM, MPOB, FRIM, LASAM.

About Prima Nexus

Prima Nexus Sdn Bhd is a Malaysian research coordination group founded in 2014. It runs hands-on training for researchers across Malaysia and eight scientific platforms under one roof: proteomics (including ELISA and Luminex multiplex immunoassays), genomics, flow cytometry, stem cell research, animal research, clinical trials, bioinformatics, and regulatory and grant support. More about Prima Nexus.

Laboratory animalsAnimal welfareVeterinary pathologyMouse models

Work with us

Planning a workshop, a study or a lab set-up? Talk to us.

We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.